The research‐based rheumatologist: Strategies to remove the species from the endangered list

E-ISSN： 1529-0131|62|12|3522-3523

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3522-3523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Derek Willoughby: an appreciation from a clinical rheumatologist

By Dieppe Paul

Inflammopharmacology, Vol. 12, Iss. 5-6, 2004-12 ,pp. : 455-460

VSP

Access to resources Recommend Favorite

The Art and Science of Risk Management: A US Research-Based Industry Perspective

By Janice K. Bush

Drug Safety, Vol. 28, Iss. 1, 2005-01 ,pp. : 1-18

Adis International

Access to resources Recommend Favorite

Impact of the Clinical Trials Directive on the Research-Based Pharmaceutical Industry

By Moira Daniels

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 1, 2004-01 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

The Research-Based Pharmaceutical Industry and Society: What Is at Stake in the Future?

By Wndisch Karl

Journal of Pharmaceutical Marketing & Management, Vol. 16, Iss. 1, 2005-01 ,pp. : 21-40

Haworth Press

Access to resources Recommend Favorite

Aptamer-Based Strategies for Stem Cell Research

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-07 ,pp. : 701-705

Bentham Science Publishers

Access to resources Recommend Favorite